+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neuroendoscopy Devices Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 147 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5805768
The global neuroendoscopy devices market value was USD 134 million in 2022, driven by the increasing demand for minimally invasive surgical techniques and advancements in technology across the globe. The market size is anticipated to grow at a CAGR of 6.9% during the forecast period of 2023-2031 to achieve a value of USD 244.2 million by 2031.

Introduction

Neuroendoscopy is a minimally invasive surgical technique used for diagnosing and treating neurological disorders within the brain and spine. Neuroendoscopy devices play a crucial role in enabling neurosurgeons to access and visualize the affected areas through small incisions or natural orifices. These devices consist of flexible or rigid endoscopes, specialized instruments, and imaging systems that provide real-time visualization and precise manipulation during neurosurgical procedures.

Key Trends in the Neuroendoscopy Devices Market

Some key trends involved in the neuroendoscopy devices market are as follows:
  • Advancements in Technology: Technological advancements have led to the development of high-definition imaging systems, miniaturized endoscopes, and sophisticated surgical instruments. These advancements enhance visualization, improve surgical precision, and allow for better patient outcomes
  • Growing Preference for Minimally Invasive Procedures: Minimally invasive neurosurgical techniques, including neuroendoscopy, are becoming increasingly popular due to their benefits such as smaller incisions, reduced trauma, shorter hospital stays, and faster recovery times. This trend is driving the demand for neuroendoscopy devices as healthcare providers and patients seek less invasive treatment options
  • Increasing Prevalence of Neurological Disorders: The prevalence of neurological disorders, such as hydrocephalus, brain tumors, and intracranial cysts, is rising globally. Neuroendoscopy devices offer effective diagnostic and treatment solutions for these conditions, leading to an increased demand for these devices
  • Rising Geriatric Population: The aging population is prone to neurological disorders and often requires neurosurgical interventions. As the geriatric population continues to grow, the demand for neuroendoscopy devices is expected to increase

Neuroendoscopy Devices Market Segmentations

Market Breakup by Product Type

  • Rigid Neuroendoscopes
  • Flexible Neuroendoscopes

Market Breakup by Applications

  • Intraventricular Neuroendoscopy
  • Transcranial Neuroendoscopy
  • Transnasal Neuroendoscopy

Market Breakup by Usability

  • Reusable Neuroendoscopes
  • Disposable Neuroendoscopes

Market Breakup by End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Neuroendoscopy Devices Market Scenario

The neuroendoscopy devices market is a rapidly growing segment of the healthcare industry, driven by the increasing demand for minimally invasive surgical techniques and advancements in technology. Neuroendoscopy devices play a crucial role in the diagnosis and treatment of various neurological disorders, allowing neurosurgeons to access and visualize the affected areas with precision.

The market is witnessing significant growth due to factors such as the rising prevalence of neurological disorders, increasing geriatric population, and the shift towards less invasive procedures. Neuroendoscopy offers several advantages over traditional open surgeries, including smaller incisions, reduced risk of complications, shorter hospital stays, and faster recovery times. These benefits have led to a growing preference for neuroendoscopic procedures among patients and healthcare providers.

Technological advancements in neuroendoscopy devices have also fueled market growth. Manufacturers are developing innovative devices with high-definition imaging capabilities, miniaturized endoscopes, and advanced surgical instruments. These advancements enhance visualization, improve procedural outcomes, and facilitate better patient care.

Additionally, the market is witnessing a shift towards outpatient and ambulatory settings, where neuroendoscopic procedures can be performed with minimal hospitalization. This trend is driven by the need to reduce healthcare costs, increase patient convenience, and improve overall healthcare efficiency.

Key players in the neuroendoscopy devices market are investing in research and development to introduce novel products and expand their product portfolios. They are also focusing on strategic collaborations and partnerships to strengthen their market presence and gain a competitive edge.

Neuroendoscopy Devices Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • adeor medical AG
  • KARL STORZ SE & Co. KG
  • Medtronic
  • B. Braun SE
  • Olympus Corporation
  • BD
  • HOYA Corporation
  • Stryker
  • Boston Scientific Corporation
  • CONMED Corporation
  • Arthrex Inc
  • Aesculap, Inc

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Neuroendoscopy Devices Market Overview
3.1 Global Neuroendoscopy Devices Market Historical Value (2016-2022)
3.2 Global Neuroendoscopy Devices Market Forecast Value (2023-2031)
4 Global Neuroendoscopy Devices Market Landscape
4.1 Global Neuroendoscopy Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Neuroendoscopy Devices Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global Neuroendoscopy Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Neuroendoscopy Devices Market Segmentation
6.1 Global Neuroendoscopy Devices Market by Product Type
6.1.1 Market Overview
6.1.2 Rigid Neuroendoscopes
6.1.3 Flexible Neuroendoscopes
6.2 Global Neuroendoscopy Devices Market by Applications
6.2.1 Market Overview
6.2.2 Intraventricular Neuroendoscopy
6.2.3 Transcranial Neuroendoscopy
6.2.4 Transnasal Neuroendoscopy
6.3 Global Neuroendoscopy Devices Market by Usability
6.3.1 Market Overview
6.3.2 Reusable Neuroendoscopes
6.3.3 Disposable Neuroendoscopes
6.4 Global Neuroendoscopy Devices Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Clinics
6.4.4 Ambulatory Surgical Centers
6.4.5 Others
6.5 Global Neuroendoscopy Devices Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Neuroendoscopy Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Neuroendoscopy Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Neuroendoscopy Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Neuroendoscopy Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Neuroendoscopy Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 adeor medical AG
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 KARL STORZ SE & Co. KG
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Medtronic
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 B. Braun SE
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Olympus Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 BD
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 HOYA Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Stryker
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Boston Scientific Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 CONMED Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Arthrex Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Aesculap, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Neuroendoscopy Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • adeor medical AG
  • KARL STORZ SE & Co. KG
  • Medtronic
  • B. Braun SE
  • Olympus Corporation
  • BD
  • HOYA Corporation
  • Stryker
  • Boston Scientific Corporation
  • CONMED Corporation
  • Arthrex Inc.
  • Aesculap Inc.

Methodology

Loading
LOADING...

Table Information